Open AccessApremilast survival and reasons for discontinuation in psoriasis: five-year experience from a Greek tertiary care centre
Author(s) -
Elena Sotiriou,
Aikaterini Tsentemeidou,
Nikolaos Sideris,
Aimilios Lallas,
Nikolaos Kougkas,
D. Ioannides,
Efstratios Vakirlis
Publication year - 2022
Publication title -
dermatology practical and conceptual
Language(s) - English
Resource type - Journals
ISSN - 2160-9381
DOI - 10.5826/dpc.1202a76
Subject(s) - apremilast , medicine , discontinuation , psoriasis , adverse effect , retrospective cohort study , proportional hazards model , confidence interval , clinical endpoint , survival analysis , surgery , clinical trial , dermatology , psoriatic arthritis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom